Apyx Medical Corporation
APYX
$0.958
$0.0788.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 48.10M | 48.54M | 49.03M | 50.45M | 52.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.10M | 48.54M | 49.03M | 50.45M | 52.35M |
| Cost of Revenue | 18.74M | 19.22M | 18.68M | 18.32M | 18.59M |
| Gross Profit | 29.36M | 29.33M | 30.35M | 32.14M | 33.76M |
| SG&A Expenses | 43.13M | 45.53M | 47.29M | 47.52M | 48.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.95M | 70.12M | 71.61M | 71.41M | 72.30M |
| Operating Income | -18.85M | -21.57M | -22.58M | -20.96M | -19.95M |
| Income Before Tax | -23.31M | -28.27M | -28.60M | -23.02M | -21.28M |
| Income Tax Expenses | 252.00K | 250.00K | -128.00K | -112.00K | -2.43M |
| Earnings from Continuing Operations | -23.56 | -28.52 | -28.48 | -22.91 | -18.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 96.00K | 82.00K | 107.00K | 102.00K | 137.00K |
| Net Income | -23.46M | -28.44M | -28.37M | -22.81M | -18.71M |
| EBIT | -18.85M | -21.57M | -22.58M | -20.96M | -19.95M |
| EBITDA | -18.25M | -20.96M | -21.92M | -20.31M | -19.26M |
| EPS Basic | -0.66 | -0.82 | -0.82 | -0.66 | -0.54 |
| Normalized Basic EPS | -0.41 | -0.45 | -0.46 | -0.41 | -0.37 |
| EPS Diluted | -0.66 | -0.82 | -0.82 | -0.66 | -0.54 |
| Normalized Diluted EPS | -0.41 | -0.45 | -0.46 | -0.41 | -0.37 |
| Average Basic Shares Outstanding | 142.15M | 138.58M | 138.57M | 138.53M | 138.49M |
| Average Diluted Shares Outstanding | 142.15M | 138.58M | 138.57M | 138.53M | 138.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
